Nutex Health Correlations
NUTX Stock | USD 104.08 9.65 8.49% |
The current 90-days correlation between Nutex Health and Claritev is 0.09 (i.e., Significant diversification). The correlation of Nutex Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Nutex Health Correlation With Market
Significant diversification
The correlation between Nutex Health and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nutex Health and DJI in the same portfolio, assuming nothing else is changed.
Moving against Nutex Stock
0.66 | GH | Guardant Health | PairCorr |
0.53 | DOCS | Doximity | PairCorr |
0.42 | VERO | Venus Concept | PairCorr |
0.4 | ECOR | Electrocore LLC | PairCorr |
0.39 | VNRX | Volitionrx | PairCorr |
0.65 | CVS | CVS Health Corp Sell-off Trend | PairCorr |
0.32 | FIGS | Figs Inc Sell-off Trend | PairCorr |
0.31 | MSPRZ | MSP Recovery Symbol Change | PairCorr |
0.46 | MODV | ModivCare | PairCorr |
0.41 | NDRA | ENDRA Life Sciences | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Nutex Stock performing well and Nutex Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nutex Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
HCTI | 16.95 | 1.53 | 0.07 | 1.05 | 19.98 | 30.05 | 258.42 | |||
CTEV | 3.51 | 1.17 | 0.33 | 1.12 | 2.69 | 7.33 | 40.80 | |||
FOXO | 7.58 | (2.27) | 0.00 | (0.73) | 0.00 | 6.67 | 204.36 | |||
FRGE | 4.74 | 1.35 | 0.18 | (30.73) | 5.46 | 12.96 | 55.54 | |||
ONCO | 6.58 | 0.14 | (0.01) | (0.20) | 8.22 | 13.77 | 47.25 | |||
ALLGF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
VRAX | 3.55 | (0.26) | 0.00 | 0.07 | 4.24 | 6.25 | 34.47 | |||
SIDU | 3.59 | 0.46 | 0.09 | 1.07 | 3.63 | 7.28 | 25.04 |
Nutex Health Corporate Management
Vivian MBA | Director Marketing | Profile | |
Mark Milliner | Controller | Profile | |
BSN JD | Chief Sec | Profile | |
Elizabeth Hall | HR Mang | Profile | |
Jennifer Rodriguez | Investor Manager | Profile | |
Jon Bates | Chief Officer | Profile |